Stay updated with breaking news from அளவிடப்பட்டது. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CELLINK launches the BIO MDX Series , a scaled-up revolution in biomedical manufacturing STOCKHOLM, March 15, 2021 /PRNewswire/ CELLINK has announced the launch of the BIO MDX Series, the next generation of bioprinters designed for high-throughput biofabrication and precision 3D bioprinting for biomedical manufacturing, including biocompatible medical devices. Over the past 5 years, as bioprinting has increasingly become the method of choice for researchers in tissue engineering, cell culturing and regenerative medicine, there has been a greater need for improved automation, precision, and reproducibility across fabrication methods. With up to six printheads, nanoliter and picoliter dispensing channels and easy robotic integration, the BIO MDX and BIO MDX+ bioprinters have been specifically designed to meet the demands of the ever-advancing cell-based technologies. ....
SMSF advice is already much like the concept of scaled advice and can be the future for the sector, but numerous regulatory guides have muddled the waters on defining scaled advice, says a technical expert. ....
ASIC barking up the wrong tree on scaled advice ASIC barking up the wrong tree on scaled advice The corporate watchdog is focusing on the wrong elements in its quest to lower the cost of advice and won’t succeed in its endeavours until record-keeping obligations on advisers are reduced, according to the head of a listed advice group. A A Easton Investments managing director Nathan Jacobsen told ifa while ASIC’s consultation on affordable advice was “a great opportunity” for the industry to have a voice around the regulatory framework, the focus on scaled advice as a starting point was flawed. ....